(NASDAQ: IOSP) Innospec's forecast annual revenue growth rate of 5.96% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 15.36%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,327.28%.
Innospec's revenue in 2026 is $1,778,000,000.On average, 5 Wall Street analysts forecast IOSP's revenue for 2026 to be $46,681,486,356, with the lowest IOSP revenue forecast at $44,203,700,456, and the highest IOSP revenue forecast at $48,738,048,653.
In 2027, IOSP is forecast to generate $49,530,940,141 in revenue, with the lowest revenue forecast at $47,523,933,562 and the highest revenue forecast at $51,042,389,540.